Financial reports
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
15 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
Current reports
8-K
Rennova Health, Inc., Announces the Expiration of Warrants to Purchare Over Four Hundred Billion Common Shares
26 Mar 24
8-K
Rennova Health, Inc. Announces Significant Debt Restructuring
31 Oct 23
8-K
Rennova Health, Inc. Provides Update after Filing 2023 Second Quarter Financial Statements
21 Aug 23
8-K
Rennova Health, Inc. Provides Update after Filing 2022 Financial Statements
24 Apr 23
8-K
Rennova Health, Inc. Provides Update on 2022 Financials and Myrtle Recovery Centers
23 Feb 23
8-K
Other Events
23 Nov 22
8-K
Rennova Health, Inc. Provides Q3 2022 Performance Update
20 Oct 22
8-K
Other Events
23 Sep 22
8-K
Rennova Health, Inc. Provides Business Update
14 Sep 22
8-K
Rennova Health, Inc. Discusses Progress and Plans for Mental and Behavioral Health Division with the Stock Day Podcast
16 Jun 22
Registration and prospectus
424B3
Prospectus supplement
26 Mar 24
424B3
Prospectus supplement
10 Jan 24
424B3
Prospectus supplement
16 May 23
S-1/A
IPO registration (amended)
9 May 23
S-1
IPO registration
30 Dec 22
D/A
$1.5M in equity / options / securities to be acquired, sold $1.5M, 2 investors
7 Apr 22
D
$1.5M in equity / options / securities to be acquired, sold $1M, 2 investors
17 Mar 22
D/A
$4M in equity / options / securities to be acquired, sold $4M, 2 investors
17 Dec 21
D
$4M in equity / options / securities to be acquired, sold $2M, 2 investors
1 Nov 21
D/A
$1M in equity / options / securities to be acquired, sold $1M, 2 investors
4 Oct 21
Proxies
DEF 14C
Information statement
16 Dec 21
PRE 14C
Preliminary information
26 Nov 21
DEF 14C
Information statement
7 Oct 21
PRE 14C
Preliminary information
22 Sep 21
DEF 14C
Information statement
17 Jun 21
PRE 14C
Preliminary information
14 May 21
DEF 14C
Information statement
8 May 20
PRE 14C
Preliminary information
12 Mar 20
PRE 14C
Preliminary information
30 Dec 19
DEF 14C
Information statement
16 Jan 19
Other
EFFECT
Notice of effectiveness
12 May 23
CORRESP
Correspondence with SEC
11 May 23
UPLOAD
Letter from SEC
4 Jan 23
EFFECT
Notice of effectiveness
26 Jul 21
CORRESP
Correspondence with SEC
21 Jul 21
CORRESP
Correspondence with SEC
2 Jul 21
UPLOAD
Letter from SEC
9 Jun 21
CORRESP
Correspondence with SEC
21 May 21
UPLOAD
Letter from SEC
3 Mar 21
UPLOAD
Letter from SEC
5 Mar 18
Ownership
SC 13D/A
Diamantis Christopher Eric
30 Sep 21
4
Christopher Eric Diamantis
30 Sep 21
4
Christopher Eric Diamantis
27 Sep 21
SC 13D
Diamantis Christopher Eric
27 Sep 21
SC 13D/A
Lagan Seamus
14 Oct 20
SC 13D/A
Lagan Seamus
26 Aug 20
SC 13G/A
Rennova Health, Inc.
22 Jan 20
SC 13D/A
Rennova Health, Inc.
25 Oct 19
3
Jonathan Immordino
15 Apr 19
SC 13D/A
Rennova Health, Inc.
21 Aug 18